Breaking News Instant updates and real-time market news.

GBT

Global Blood Therapeutics

$37.35

0.45 (1.22%)

, NVO

Novo Nordisk

$34.23

0.21 (0.62%)

07:34
03/21/17
03/21
07:34
03/21/17
07:34

Global Blood Therapeutics coverage assumed with an Outperform at Wedbush

Wedbush analyst Liana Moussatos says that Global Blood Therapeutics' (GBT) GBT440 drug can become the standard of care for sickle cell disease, and he thinks that the stock has not risen adequately following speculation that the company had been approached by Novo Nordisk(NVO) about a takeover. The analyst thinks that the company could be acquired for $73-$87 per share, versus its current price of around $37. Target $73.

GBT

Global Blood Therapeutics

$37.35

0.45 (1.22%)

NVO

Novo Nordisk

$34.23

0.21 (0.62%)

  • 23

    Mar

GBT Global Blood Therapeutics
$37.35

0.45 (1.22%)

01/04/17
JPMS
01/04/17
INITIATION
Target $25
JPMS
Overweight
Global Blood Therapeutics initiated with an Overweight at JPMorgan
JPMorgan analyst Cory Kasimov started Global Blood Therapeutics with an Overweight rating and $25 price target. If successful, the company's GBT440 would be the first new sickle cell disease therapy approved in two decades, Kasimov tells investors in a research note. He's "encouraged" by the Phase 1/2 data to date and thinks the recent share selloff creates a long-term buying opportunity.
01/04/17
01/04/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Guggenheim analyst Robert Cihra initiated Apple (AAPL) with a Buy rating and $140 price target, stating that while iPhones have slowed to now being cyclical he thinks the company can stay a step ahead of commoditization by maintaining its lead in software with iOS and processing with the Ax chip. 2. JPMorgan analyst Cory Kasimov started Global Blood Therapeutics (GBT) with an Overweight rating and $25 price target. If successful, the company's GBT440 would be the first new sickle cell disease therapy approved in two decades, Kasimov tells investors. 3. Needham analyst Laura Martin initiated Priceline (PCLN) with a Buy and a $1,800 price target due to its market lading position, history of execution, and OTA ecosystem competitive advantages. 4. Canaccord analyst Richard Close initiated Teladoc (TDOC) with a Buy rating and $24 price target. Close said Teladoc is the first mover, industry leader and the only publicly traded telemedicine company. 5. Guggenheim analyst Robert Cihra initiated Tesla (TSLA) with a Buy rating and $280 price target, as he acknowledges it faces a number of risks but also has "nearly open-ended growth disrupting the trillion-dollar auto market." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/01/17
NOMU
03/01/17
INITIATION
Target $50
NOMU
Buy
Global Blood Therapeutics initiated with a Buy at Nomura
Nomura initiated Global Blood Therapeutics with a Buy and a $50 price target.
03/15/17
CANT
03/15/17
INITIATION
CANT
Overweight
Global Blood Therapeutics initiated with an Overweight at Cantor
NVO Novo Nordisk
$34.23

0.21 (0.62%)

01/04/17
JPMS
01/04/17
DOWNGRADE
JPMS
Underweight
Novo Nordisk downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Richard Vosser downgraded Novo Nordisk yesterday to Underweight saying consensus expectations are not reflecting the potential for further pricing pressure in the U.S. The analyst has a DKR 225 price target for the shares.
02/02/17
DBAB
02/02/17
NO CHANGE
DBAB
Novo Nordisk added to short-term buy list at Deutsche Bank
03/07/17
LEHM
03/07/17
INITIATION
LEHM
Underweight
Novo Nordisk reinstated with an Underweight at Barclays
Barclays analyst Emmanuel Papadakis reinstated Novo Nordisk with an Underweight rating and DKK 210 price target. The analyst believes the valuation premium to the group is unwarranted and feels the company's 2017 guidance "does not look cautious."
03/07/17
LEHM
03/07/17
NO CHANGE
LEHM
European Pharma raised to Positive from Neutral at Barclays
Barclays analyst Emmanuel Papadakis rolled out coverage of the European Pharmaceuticals space and upgraded his sector view to Positive from Neutral. The analyst has "high conviction that the recent transformational era of R&D innovation is set to continue," which he believes will allow the sector to retain pricing power. Papadakis put Overweight ratings on AstraZeneca (AZN), Roche (RHHBY) and Shire (SHPG), with Astra his top pick. The analyst put an Equal Weight rating on GlaxoSmithKline (GSK) and Underweight ratings on Sanofi (SNY), Novartis (NVS) and Novo Nordisk (NVO).

TODAY'S FREE FLY STORIES

ABT

Abbott

$56.32

0.32 (0.57%)

, MD

Mednax

07:36
10/23/17
10/23
07:36
10/23/17
07:36
Conference/Events
American Society of Anesthesiology to hold annual meeting »

Anesthesiology 2017…

ABT

Abbott

$56.32

0.32 (0.57%)

MD

Mednax

ABBV

AbbVie

$96.10

-0.38 (-0.39%)

BAX

Baxter

$63.59

0.12 (0.19%)

CAE

CAE

$17.43

0.01 (0.06%)

DDD

3D Systems

$12.00

0.53 (4.62%)

EM

Emdeon

XENE

Xenon Pharmaceuticals

$3.25

0.05 (1.56%)

TRVN

Trevena

$1.76

0.1 (6.02%)

SIEGY

Siemens

$68.33

-1.245 (-1.79%)

NOVA

NovaMed

NUVA

NuVasive

$55.05

0.48 (0.88%)

PFE

Pfizer

$36.42

0.18 (0.50%)

INFI

Infinity Pharmaceuticals

$2.28

-0.12 (-5.00%)

KRO

Kronos Worldwide

$26.17

0.35 (1.36%)

MNK

Mallinckrodt

$32.42

-0.4 (-1.22%)

HAE

Haemonetics

$45.66

0.55 (1.22%)

EW

Edwards Lifesciences

$113.08

1.05 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 27

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 07

    Dec

CMCSA

Comcast

$37.22

0.32 (0.87%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Recommendations
Comcast analyst commentary  »

Comcast video losses do…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 01

    Nov

ENTA

Enanta

$48.16

0.76 (1.60%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Hot Stocks
Enanta announces 'positive' Phase 1 a/b clinical results for EDP-305 »

Enanta Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark sees FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

VZ

Verizon

$49.53

0.32 (0.65%)

, UNP

Union Pacific

$112.99

0.98 (0.87%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

VZ

Verizon

$49.53

0.32 (0.65%)

UNP

Union Pacific

$112.99

0.98 (0.87%)

S

Sprint

$6.93

-0.14 (-1.98%)

PYPL

PayPal

$70.97

3.72 (5.53%)

CTL

CenturyLink

$19.04

0.55 (2.97%)

NSC

Norfolk Southern

$132.75

2.51 (1.93%)

FEYE

FireEye

$16.81

-0.01 (-0.06%)

AMTD

TD Ameritrade

$48.27

0.88 (1.86%)

PRU

Prudential

$110.78

1.18 (1.08%)

AVP

Avon Products

$2.28

0.02 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 07

    Nov

  • 07

    Nov

  • 15

    Nov

  • 29

    Nov

  • 07

    Dec

  • 16

    May

MRK

Merck

$63.88

0.13 (0.20%)

, TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.07

-0.15 (-0.53%)

07:34
10/23/17
10/23
07:34
10/23/17
07:34
Conference/Events
World Congress to hold a summit »

5th Annual Patient…

MRK

Merck

$63.88

0.13 (0.20%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.07

-0.15 (-0.53%)

PFE

Pfizer

$36.42

0.18 (0.50%)

AGN

Allergan

$188.28

-0.99 (-0.52%)

ONCE

Spark Therapeutics

$81.87

1.08 (1.34%)

PODD

Insulet

$61.58

-0.39 (-0.63%)

ACHN

Achillion

$4.15

-0.01 (-0.24%)

SNY

Sanofi

$49.51

-0.51 (-1.02%)

ABEO

Abeona Therapeutics

$19.00

1.25 (7.04%)

JNJ

Johnson & Johnson

$142.40

0.36 (0.25%)

AZN

AstraZeneca

$34.62

-0.09 (-0.26%)

SHPG

Shire

$145.25

-2.57 (-1.74%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

BMY

Bristol-Myers

$64.42

-0.25 (-0.39%)

SCMP

Sucampo

$10.30

0.05 (0.49%)

PCRX

Pacira

$33.50

0.4 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 27

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 16

    Nov

  • 30

    Nov

  • 12

    Jan

  • 02

    Feb

  • 05

    Mar

  • 06

    Apr

AAPL

Apple

$156.25

0.27 (0.17%)

07:34
10/23/17
10/23
07:34
10/23/17
07:34
Recommendations
Apple analyst commentary  »

Apple supply/demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Hot Stocks
T-Mobile raises low end of postpaid net custuomer adds view to 3.3M-3.6M »

T-Mobile says, "We…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Hot Stocks
Kimberly-Clark says Q3 a 'challenging environment' »

Chairman and CEO Thomas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Conference/Events
The U.S. Commodity Futures Trading Commission holds a symposium »

25th Annual Symposium is…

BKS

Barnes & Noble

$7.35

0.15 (2.08%)

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Conference/Events
Barnes & Noble management to meet with Sidoti »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Hot Stocks
T-Mobile sees FY branded postpaid phone ARPU 'generally stable' to FY16 »

T-Mobile continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

DCPH

Deciphera

$20.15

0.31 (1.56%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Initiation
Deciphera initiated  »

Deciphera initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Earnings
Kimberly-Clark backs FY17 EPS view at low end of $6.20-$6.35 »

FY17 consensus $6.20. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ZKIN

ZK International Group

$8.23

0.07 (0.86%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Hot Stocks
ZK International Group invited by Shenzhen Water Group »

ZK International Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

07:31
10/23/17
10/23
07:31
10/23/17
07:31
Earnings
T-Mobile reports Q3 EPS 63c, consensus 46c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

EGL

Engility

$33.41

-0.11 (-0.33%)

07:31
10/23/17
10/23
07:31
10/23/17
07:31
Hot Stocks
Engility wins $14M contract from Defense Intelligence Agency »

Engility Holdings won a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 09

    Nov

  • 14

    Dec

ROKU

Roku

$21.87

-0.16 (-0.73%)

07:31
10/23/17
10/23
07:31
10/23/17
07:31
Initiation
Roku initiated  »

Roku initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

DHI

D.R. Horton

$42.67

0.14 (0.33%)

07:30
10/23/17
10/23
07:30
10/23/17
07:30
Recommendations
D.R. Horton analyst commentary  »

D.R. Horton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 14

    Nov

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:30
10/23/17
10/23
07:30
10/23/17
07:30
Earnings
Kimberly-Clark reports Q3 EPS $1.60, consensus $1.54 »

Reports Q3 revenue $4.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

WFT

Weatherford

$3.54

-0.16 (-4.32%)

, BSX

Boston Scientific

$29.69

0.12 (0.41%)

07:30
10/23/17
10/23
07:30
10/23/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

WFT

Weatherford

$3.54

-0.16 (-4.32%)

BSX

Boston Scientific

$29.69

0.12 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 01

    Nov

  • 06

    Nov

VFC

VF Corp.

$66.38

1.03 (1.58%)

07:29
10/23/17
10/23
07:29
10/23/17
07:29
Technical Analysis
Technical View: VF Corp. hits fresh 52-week high after earnings beat »

The stock was last at $69…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HAS

Hasbro

$98.19

1.52 (1.57%)

07:28
10/23/17
10/23
07:28
10/23/17
07:28
Earnings
Hasbro sees Q4 revenue up 4%-7%, consensus $1.82B »

"The quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SALT

Scorpio Bulkers

$8.20

0.45 (5.81%)

07:28
10/23/17
10/23
07:28
10/23/17
07:28
Earnings
Scorpio Bulkers reports Q3 GAAP EPS (15c), consensus (13c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ALGN

Align Technology

$200.88

4.03 (2.05%)

07:28
10/23/17
10/23
07:28
10/23/17
07:28
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.